www.ajmc.com Open in urlscan Pro
76.76.21.142  Public Scan

Form analysis
2 forms found in the DOM

GET /search

<form method="GET" action="/search" class="flex items-center justify-between w-full"><input type="text" name="searchTerm" placeholder="SEARCH" class="bg-white p-1 rounded-md border-0 w-[80%] text-black" required=""><input type="submit" value="SEARCH"
    class="ml-2 cursor-pointer bg-search-box-button-bg text-search-box-button-text hover:bg-search-box-button-hover-bg hover:text-search-box-button-hover-text ronded rounded-md p-1 font-bold w-[20%]"></form>

GET /search

<form method="GET" action="/search" class="flex items-center justify-between w-full"><input type="text" name="searchTerm" placeholder="SEARCH" class="bg-white p-1 rounded-md border-0 w-[80%] text-black" required=""><input type="submit" value="SEARCH"
    class="ml-2 bg-search-box-button-bg text-search-box-button-text ronded rounded-md p-1 font-bold w-[20%]"></form>

Text Content

 * 
 * 

News
All News
Partners
Press Releases
Product Approvals and Launches
Media
Clinical Spotlight
Enduring Webinars
Guidelines
Insights
Interviews
Microsites
News Network
OnLocation
Payer Perspectives
Peer Exchange
Podcasts
Post Conference Perspectives
Sponsored
Stakeholder Summit
Week in Review
Conferences
Conference Coverage
Conference Listing
Journals
Submit a Manuscript
All Journals
The American Journal of Managed Care
The American Journal of Accountable Care
Evidence-Based Oncology
Supplements and Featured Publications
Compendia
ALL/AML
Alopecia
Asthma
Atopic Dermatitis
Autoimmune
Biosimilars
Breast Cancer
CLL/SLL
COPD
COVID-19
Cardiovascular
Colorectal Cancer
DLBCL
Dermatology
Diabetes
Duchenne Muscular Dystrophy
Employers
Gastroenterology
Gene Therapy
Graft-vs-Host Disease (GVHD)
HIV
Heart Failure
Hemophilia
Idiopathic Pulmonary Fibrosis
Immuno-Oncology
Immunology
Leukemia and Lymphoma
Liver Cancer
Lung Cancer
Medicare
Mental Health
Multiple Myeloma
Multiple Sclerosis
Myasthenia Gravis
Myelodysplastic Syndromes
Myeloproliferative Neoplasms (MPN)
Non–Small Cell Lung Cancer
Obesity
Oncology
Ophthalmology
Ovarian Cancer
Population Health
Psoriasis
Pulmonary Arterial Hypertension
RSV
Rare Blood
Reimbursement
Skin Cancer
Sleep
Soft Tissue Sarcoma
Type 1 Diabetes
Events
Events
Upcoming Webinars
CME/CE
Resources
Exclusive Content
Formulary Central
Interactive Tools
Subscribe



Stakeholders
AcademiaEmployersHealth SystemPayersProviders
Topics
Center on Health Equity and AccessClinicalHealth Care CostHealth Care
DeliveryInsurancePolicyTechnologyValue-Based Care
Institute for Value-Based Medicine
All CoverageEvent CoverageInterviewsNews
About AJMC
AJMC JournalsAnniversaryAuthor FormsAuthorsNominate a Rising LeaderSubmit a
Manuscript
News
All News
Partners
Press Releases
Product Approvals and Launches
Media
Clinical Spotlight
Enduring Webinars
Guidelines
Insights
Interviews
Microsites
News Network
OnLocation
Payer Perspectives
Peer Exchange
Podcasts
Post Conference Perspectives
Sponsored
Stakeholder Summit
Week in Review
Conferences
Conference Coverage
Conference Listing
Journals
Submit a Manuscript
All Journals
The American Journal of Managed Care
The American Journal of Accountable Care
Evidence-Based Oncology
Supplements and Featured Publications
Compendia
ALL/AML
Alopecia
Asthma
Atopic Dermatitis
Autoimmune
Biosimilars
Breast Cancer
CLL/SLL
COPD
COVID-19
Cardiovascular
Colorectal Cancer
DLBCL
Dermatology
Diabetes
Duchenne Muscular Dystrophy
Employers
Gastroenterology
Gene Therapy
Graft-vs-Host Disease (GVHD)
HIV
Heart Failure
Hemophilia
Idiopathic Pulmonary Fibrosis
Immuno-Oncology
Immunology
Leukemia and Lymphoma
Liver Cancer
Lung Cancer
Medicare
Mental Health
Multiple Myeloma
Multiple Sclerosis
Myasthenia Gravis
Myelodysplastic Syndromes
Myeloproliferative Neoplasms (MPN)
Non–Small Cell Lung Cancer
Obesity
Oncology
Ophthalmology
Ovarian Cancer
Population Health
Psoriasis
Pulmonary Arterial Hypertension
RSV
Rare Blood
Reimbursement
Skin Cancer
Sleep
Soft Tissue Sarcoma
Type 1 Diabetes
Events
Events
Upcoming Webinars
CME/CE
Resources
Exclusive Content
Formulary Central
Interactive Tools
Subscribe

Choose a Specialty
 * Center on Health Equity and Access
 * Clinical
 * Health Care Cost
 * Health Care Delivery
 * Insurance
 * Policy
 * Technology
 * Value-Based Care

Advertisement

Stakeholders
AcademiaEmployersHealth SystemPayersProviders
Topics
Center on Health Equity and AccessClinicalHealth Care CostHealth Care
DeliveryInsurancePolicyTechnologyValue-Based Care
Institute for Value-Based Medicine
All CoverageEvent CoverageInterviewsNews
About AJMC
AJMC JournalsAnniversaryAuthor FormsAuthorsNominate a Rising LeaderSubmit a
Manuscript


LATEST NEWS


Immunotherapy Before Noon Linked to Improved Survival in mRCC
By Mary Caffrey
March 28th 2024

Results are consistent with the authors' prior findings on the possible effects
of circadian rhythm on outcomes after immunotherapy.

Analysis Highlights Potential Gaps Between Popularity, Credibility of
Asthma-Related TikTok Videos
By AJMC Contributor
March 28th 2024
Undertreatment, Biologic Access Gaps Identified in Psoriasis Treatment
By Pearl Steinzor
March 28th 2024
FDA Approves Ravulizumab-cwvz for Rare Autoimmune Disease
By Pearl Steinzor
March 28th 2024
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged
Discharge Struggles
By Maggie L. Shaw
March 28th 2024


CONFERENCE COVERAGE

View All
Undertreatment, Biologic Access Gaps Identified in Psoriasis Treatment
By Pearl Steinzor

March 28th 2024

Posters presented at the American Academy of Dermatology Annual Meeting
identified significant undertreatment of psoriasis and significant gaps in
biologic medication treatment.

The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in
the US
By Giuliana Grossi

March 26th 2024

A presentation at the Greater Philadelphia Business Coalition on Health's 2024
Women’s Health Summit discussed how payers, including employers and public
entities, can strategically influence health care purchasing to prioritize
maternal health and equity.

Dr Raj Chovatiya Provides Evidence Supporting Oral JAK Inhibitor Use to Treat AD
By Brooke McCormick
Pearl Steinzor

March 24th 2024

Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University
of Medicine and Science, provided current clinical evidence supporting the use
of oral Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis
(AD).

Gaps in Skincare Knowledge, Sun Protection Practice Exist Among Patients With
Lupus
By Brooke McCormick

March 21st 2024

This poster reported that photoprotection management of lupus is unaffordable
for some patients, which may have an impact on sunscreen application frequency.

Latest Videos
Value-Based Care Models Optimizing Ph+ ALL Patient Care

Diagnosing and Understanding the Pathogenesis of Bronchiectasis

Key RRMM-Related Takeaways from ASH 2023

Identifying Social Determinants of Health in Cardiovascular Care

The Promise of Frexalimab in MS: Part 3

Pat Van Burkleo: Feeding Louisiana Helps Address Underutilized SNAP Benefits in
Community

Advancements in Hemophilia A Therapies: Altuviiio and Roctavian

Challenges in Autoantibody Screening for Type 1 Diabetes

Dr Jeff Stark: Patients With Hidradenitis Suppurativa Have Improved Pain
Management With Bimekizumab

Coverage of Gene Therapies: Balancing Cost, Clinical Impact, and Durability of
Effect

Interpreting Clinical Data to Guide Coverage Decisions for Rare Disease
Therapies

PhALLCON Trial: Efficacy and Safety of Ponatinib in Ph+ ALL Patients

Recent Data Reveals Disparities in Cardiovascular Care

Dr Raj Chovatiya Provides Evidence Supporting Oral JAK Inhibitor Use to Treat AD

Dr Robert Groves: Society's Role in Addressing Social Determinants of Health

Dr Raajit Rampal Highlights Emerging Therapies in MPNs

Optimizing Hemophilia Treatment: Strategies and Adherence

JNJ-2113 Shows Promising Response Rates Compared With Competitor Oral Therapies
for Psoriasis

Dr Padma Sripada on Providing Personalized, High-Quality Primary Care Amid
Workforce Shortages

Identifying Risk to Enable Early Detection of Type 1 Diabetes



CONVERSATIONS WITH INNOVATORS AND CHANGEMAKERS IN CANCER CARE

Justin Bekelman, MD, Penn Center for Cancer Care Innovation, emphasizes
collaboration between academic medicine and community oncology, highlighting
innovative cancer care delivery in these contexts.


PATIENT-CENTERED ONCOLOGY CARE®

Join us for our annual event, with a theme focused on Innovations in Cancer
Care: Tales From the Front Line.

Latest From Journals

--------------------------------------------------------------------------------

Breaking Barriers: Partnerships to Improve Diabetic Eye Health in Alabama

Delivering on the Promise of Accountable and Value-Based Care

Can Different Pricing Models Address the Obesity Problem in America?

The Socratic Method May Save Health Care

Rule Change for Patient Navigation Billing Is a Boon to Oncology Care, Practice
Leaders Say

OneOncology Partners With Clearview Cancer Institute and Names New Disease Group
Chairs; FCS Appoints Executive Board Members

To Attain Diversity in Clinical Trial Enrollment, It Takes a Village

Tennessee Oncology’s Brandes Sees Progress in Biomarker Use in NSCLC, but
“There’s Work to Be Done”

"Interventions Are Needed at Every Step"

Scaling Care Coordination Through Digital Engagement: Stepped-Wedge Trial
Assessing Readmissions

Potential Inequities in Access to In-Person SHIP Counseling Services

Facts About Hospital-Insurer Contracting

Overcoming Barriers to Care Equity in Multiple Myeloma

ASH Abstracts Showcase Effective Treatments for MM, CLL, FL

The Health Information Technology Special Issue: Making Innovations Impactful,
Ethical, and Equitable

Racial/Ethnic Differences in Autoimmune Disease Prevalence in US Claims/EHR Data

Cardiovascular Disease Risk Management During COVID-19: In-Person vs Virtual
Visits

Data Reveal Racial, SDOH Factors Linked to OS Differences in CLL

Controlling Costs and Enhancing the Patient Journey in a Changing Pharmaceutical
Landscape

In Louisiana, Efforts to Address Obesity Must Consider the Whole Person, Work
Outside the Clinic, and Respect Culture

Gestational Diabetes Is a Key Population Health Opportunity

Operating Room Efficiency of Orthopedic Surgery During the COVID-19 Era

Therapists’ Perspectives on Access to Telemental Health Among Medicaid-Enrolled
Youth

Incidence and Cost of Potentially Avoidable Emergency Department Visits for
Urolithiasis

A Clinical Pathway to Well-Being: Putting Patient Priorities at the Center of
Care

Primary Care Transformation: A Team-Based Care Model

Advancing Team-Based Primary Care: The Importance and Challenges in 2023

Continuing Medical Education

On-Demand WebinarOn-Demand

2022 ASH Annual Meeting Coverage—Recent Developments in Diffuse Large B-Cell
Lymphoma: Insights and Application for Managed Care

1.0 Credit / Oncology

View More




AJMC SupplementOn-Demand

CAR T-Cell Therapy Advances in Lymphoma: Implications for Managed Care

1.5 Credits / Hematology, Oncology

View More




Online ArticleOn-Demand

An Article in the American Journal of Managed Care’s Evidence-Based Oncology:
Navigating the Complexities of Frontline Immunotherapy in NSCLC

2 Credits / Oncology, Pulmonology/Respiratory

View More




AJMC SupplementOn-Demand

Uncovering the Economic Burden of Chronic Cough and the Promising Role of
Emerging Targeted Therapies

3.0 Credits / Pulmonology/Respiratory

View More




Online ArticleOn-Demand

Evidence-Based Oncology: Discerning Novel Approaches, Recent Advances, and the
Managed Care Considerations for Targeted Treatments in CLL

2.0 Credits / Hematology, Oncology

View More




On-Demand Virtual SymposiumOn-Demand

Leveraging Managed Care to Optimize Patient Outcomes in Acute Myeloid Leukemia

1.5 Credits / Hematology, Oncology

View More




On-Demand Virtual SymposiumOn-Demand

Discussions on Recent Data and Best Practices for Managed Care in the Treatment
of nAMD and DME

1.5 Credits / Ophthalmology/Optometry

View More




On-Demand Virtual SymposiumOn-Demand

Leveraging Managed Care to Increase Access to BCMA-Directed Treatment and
Equitable Care in Multiple Myeloma

1.5 Credits / Hematology, Oncology

View More






ALL NEWS



FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis

By Cameron Santoro
March 28th 2024


The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in
adult patients with chronic kidney disease (CKD) on dialysis for at least 3
months. This fills a need for a new treatment option as anemia is common in
these patients and can significantly impact their quality of life.



Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as
Men Age

By Kyle Munz
March 28th 2024


A population-based cohort study out of Norway has found that older men have a
higher risk of developing second primary invasive melanoma following an initial
primary melanoma, suggesting the benefits of increased surveillance in these
patients.



Oncologists Find Ethical Challenges With Artificial Intelligence in Cancer Care

By Pearl Steinzor
March 28th 2024


Explainability, consent, and responsibility are noted as challenges that may
hinder implementation of artificial intelligence (AI) in cancer care, according
to a new study.



Wearable Activity Tracker Data Enhance Patient Assessment in Lung Cancer

By Maggie L. Shaw
March 28th 2024


This analysis included 119 patients with advanced lung cancer, who were
evaluated on 3 facets of physical activity over 14 days of using the amuelink
wearable device from Sony: metabolic equivalent tasks, distance walked, and
steps taken.



What We’re Reading: Simplified CHIP Enrollment; Inpatient Rehab Facility Pay
Bump; Health Care Marketing Arrangement Dangers

By AJMC Staff
March 28th 2024


CMS released a final rule to help patients obtain Children’s Health Insurance
Program (CHIP) coverage and issued a proposed rule to update Medicare payment
policies and rates for inpatient rehabilitation facilities; debate over if gift
card incentives are acceptable in health care marketing.



Patients With Autoimmune Thyroid Disease at Higher Risk of Myasthenia Gravis

By AJMC Contributor
March 28th 2024


These insights, explain the researchers of the study, complement observational
studies, which have previously indicated a causal relationship between the 2
diseases.



Dr Chakra Chaulagain: PFS Is the "Bare Minimum," but OS Is Ideal for Choosing
Between MM Therapies

By AJMC Staff
March 28th 2024


Response rates are important when choosing between therapies to treat multiple
myeloma (MM), but improvement overall survival (OS) is the ideal, said Chakra
Chaulagain MD, FACP, hematologist/oncologist, Maroone Cancer Center of Cleveland
Clinic Florida.



Study Supports Use of EORTC Item Library to Assess Lymphoma Symptoms

By Luke Halpern
March 27th 2024


Clinician and patient interviews indicated satisfaction with the items presented
to help describe patient symptoms with different lymphomas.



Alopecia Areata Impacts Patient Perception, Quality of Life

By Cameron Santoro
March 27th 2024


Patients with alopecia areata (AA) often perceive their hair loss as more severe
than dermatologists do, leading to increased emotional and social problems. This
study highlights the importance of understanding patient perception for better
treatment and improved quality of life.



Younger Patients With PV May Benefit From Earlier Treatment With Cytoreductive
Therapies

By Laura Joszt, MA
March 27th 2024


For most patients younger than age 60 with polycythemia vera (PV) who are not
considered high risk, cytoreductive therapies are withheld despite being highly
effective.



What We’re Reading: Abortion Pill Access Arguments; Clinical Research Site
Inspections; AstraZeneca 340B Lawsuit

By AJMC Staff
March 27th 2024


The Supreme Court seems likely to reject a challenge to the abortion pill
mifepristone; the FDA is inspecting far fewer pharmaceutical companies
conducting clinical research; AstraZeneca has sued to block an Arkansas law that
it said would unlawfully expand the 340B program to include for profit-pharmacy
chains.



Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma

By Maggie L. Shaw
March 27th 2024


Investigators used the Functional Assessment of Cancer Therapy-General General
Physical Wellbeing Scale to collect data on patient-reported treatment-related
adverse effects, to provide clinicians guidance on predicting risk of early
treatment discontinuation among ECOG-ACRIN E1A11 trial participants.



FDA Approves Sotatercept, First-in-Class Treatment for Adults With PAH

By Julia Bonavitacola
March 26th 2024


Adults with pulmonary arterial hypertension (PAH) have a new treatment available
with the FDA approval of sotatercept (Winrevair; Merck), an activin signaling
inhibitor biologic.



Intraocular Inflammation, Retinal Vascular Occlusion Infrequent in Treatment
With Brolucizumab

By Julia Bonavitacola
March 26th 2024


A real-world safety study found that patients treated with brolucizumab had low
occurrences of intraocular inflammation, retinal vascular occlusion, and retinal
vasculitis.



Pegylated Interferons Have Promise but Also Unmet Potential in MPNs

By Jared Kaltwasser
March 26th 2024


Despite potential benefits, the therapy remains in limited use for
myeloproliferative neoplasms (MPNs).



Radiation Therapy Associated With Elevated Skin Cancer Risk in Patients With
Breast Cancer

By Kyle Munz
March 26th 2024


Results from a retrospective cohort study analyzing patients with breast cancer
bolster reports of an association between radiation therapy and subsequent risks
of skin cancers.



What We’re Reading: Chemotherapy Overdoses; Digital Diabetes Management Tools;
Pneumonia Misdiagnosis

By AJMC Staff
March 26th 2024


Lack of routine testing can lead to tragic consequences for patients with
cancer; an analysis raises questions about clinical benefits of digital diabetes
management tools; overuse of antibiotics poses risks to patients with a
misdiagnosis of pneumonia.



Venetoclax Resistance in Patients With MDS Explained in New Study

By Jared Kaltwasser
March 26th 2024


The report offers new insights into the limits of the BCL2 inhibitor among
patients who have myelodysplastic syndromes.



The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in
the US

By Giuliana Grossi
March 26th 2024


A presentation at the Greater Philadelphia Business Coalition on Health's 2024
Women’s Health Summit discussed how payers, including employers and public
entities, can strategically influence health care purchasing to prioritize
maternal health and equity.



Exploring Medicare Advantage Prior Authorization Variations

By Brooke McCormick
March 26th 2024


On this episode of Managed Care Cast, we're talking with the authors of a study
published in the March 2024 issue of The American Journal of Managed Care® about
their findings on variations in prior authorization use across Medicare
Advantage plans.



Late Presentation of HIV Most Common in Older Patients

By Julia Bonavitacola
March 26th 2024


Older patients and patients of sub-Saharan African origin were at an increased
risk of late presentation of advanced HIV.



Dupilumab Reduces Asthma Symptoms Regardless of Exacerbation History, Study
Finds

By Pearl Steinzor
March 25th 2024


Dupilumab significantly reduced the risk of exacerbations compared with placebo
in children with moderate to severe asthma, regardless of exacerbation history.



FDA Issues CRLs for Odronextamab in R/R Follicular Lymphoma, R/R DLBCL

By Rose McNulty
March 25th 2024


The FDA issued complete response letters (CRLs) for the biologics license
application for odronextamab in relapsed/refractory (R/R) follicular lymphoma
and in R/R diffuse large B-cell lymphoma (DLBCL).



Cetuximab Effective in Patients With CRC After Induction Chemotherapy

By Julia Bonavitacola
March 25th 2024


A study found that cetuximab along or with chemotherapy was an effective option
in patients with metastatic colorectal cancer (CRC).



FDA Approves Macitentan, Tadalafil Combination Tablet for Pulmonary Arterial
Hypertension

By Rose McNulty
March 25th 2024


The approval, which marks the first for a once-daily, single-tablet combination
therapy for pulmonary arterial hypertension, is based on findings from the phase
3 A DUE study.


See All News >
Advertisement

Recent Content

Immunotherapy Before Noon Linked to Improved Survival in mRCC



Analysis Highlights Potential Gaps Between Popularity, Credibility of
Asthma-Related TikTok Videos



Undertreatment, Biologic Access Gaps Identified in Psoriasis Treatment



FDA Approves Ravulizumab-cwvz for Rare Autoimmune Disease

View More Recent Content
Advertisement

Advertisement

x

About Us
Contact
Editorial Staff
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777



© 2024 MJH Life Sciences
AJMC®
All rights reserved.